These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 24544513

  • 1. The effects of vancomycin, oleandomycin, and novobiocin and staphylococci in vitro.
    RANTZ LA, RANDALL E, THUM L, BARKER LF.
    Antibiot Chemother (Northfield); 1957 Aug; 7(8):399-409. PubMed ID: 24544513
    [No Abstract] [Full Text] [Related]

  • 2. Staphylococcal resistance to ristocetin, oleandomycin, and novobiocin.
    HSIE JY, NUSSER W, EPSTEIN S, VAN MAREN H, OZOG S.
    Antibiot Chemother (Northfield); 1958 Dec; 8(12):607-14. PubMed ID: 24545054
    [No Abstract] [Full Text] [Related]

  • 3. In vitro sensitivity of erythromycin-resistant strains of staphylococci and enterococci to vancomycin and novobiocin.
    SCHNEIERSON SS, AMSTERDAM D.
    Antibiot Chemother (Northfield); 1957 May; 7(5):251-4. PubMed ID: 24544426
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Novobiocin and PA 105: in vitro and in vivo studies on effectiveness against Micrococcus pyogenes.
    NOYES HE, NAGLE SC, SANFORD JP, ROBBINS ML.
    Antibiot Chemother (Northfield); 1956 Jul; 6(7):450-5. PubMed ID: 24544026
    [No Abstract] [Full Text] [Related]

  • 6. Laboratory studies of oleandomycin (matromycin).
    GERACI JE, NEEDHAM GM.
    Antibiotic Med Clin Ther (New York); 1956 Oct; 3(5):334-5. PubMed ID: 13363377
    [No Abstract] [Full Text] [Related]

  • 7. A comparison of erythromycin with oleandomycin in combination with other antibiotics against hospital staphylococci.
    ELLIOTT HJ, HALL WH.
    J Lab Clin Med; 1959 Mar; 53(3):364-75. PubMed ID: 13631321
    [No Abstract] [Full Text] [Related]

  • 8. In vitro sensitivity of 300 strains of Micrococcus pyogenes isolated from carriers to seven antibiotics; the problem of the resistant Staphylococci in Chile.
    PAREDES L, VACCARO H, VALENZUELA E.
    Antibiot Annu; 1959 Mar; 3():623-33. PubMed ID: 13355339
    [No Abstract] [Full Text] [Related]

  • 9. Influence of a combination of sodium sulfisoxazole and oleandomycin phosphate on the development of drug resistance of Micrococcus pyogenes var. aureus in vitro.
    DELORENZO WF.
    Antibiot Chemother (Northfield); 1958 Feb; 8(2):84-5. PubMed ID: 24544672
    [No Abstract] [Full Text] [Related]

  • 10. The effect of fixed combinations of antibiotics on Staphylococci in vitro.
    FURESZ S, ZANGAGLIA O, SCOTTI R.
    Antibiot Chemother (Northfield); 1958 Nov; 8(11):571-5. PubMed ID: 24544980
    [No Abstract] [Full Text] [Related]

  • 11. The action of antibiotic combinations on pathogenic staphylococci in vitro.
    MANTEN A.
    Antibiot Chemother (Northfield); 1956 Aug; 6(8):480-6. PubMed ID: 24544085
    [No Abstract] [Full Text] [Related]

  • 12. A comparison of the in vitro effectiveness of kanamycin and nine other antibiotics against staphylococci.
    GRIFFITH LJ, OSTRANDER WE.
    Antibiot Chemother (Northfield); 1959 Jul; 9(7):416-8. PubMed ID: 24545275
    [No Abstract] [Full Text] [Related]

  • 13. [Anti-staphylococcal activity of novobiocin].
    Chabbert Y, Berrod J, Henoch H, Dumas J.
    Presse Med (1893); 1958 May 07; 66(36):809 passim. PubMed ID: 13567446
    [No Abstract] [Full Text] [Related]

  • 14. The in vitro antibiotic activity of novobiocin on M. pyogenes and some intestinal gram-negative bacteria.
    COPPO A.
    Antibiot Chemother (Northfield); 1957 Jun 07; 7(6):297-305. PubMed ID: 24544434
    [No Abstract] [Full Text] [Related]

  • 15. In-vitro activity of sigmamycin: a combination of tetracycline and oleandomycin.
    FAIRBROTHER RW, SOUTHALL JE.
    Lancet; 1957 Nov 16; 273(7003):974-6. PubMed ID: 13482262
    [No Abstract] [Full Text] [Related]

  • 16. The participation of novobiocin and vancomycin in combined antibiotic action against staphylococci.
    BERTIE W, JAWETZ E, SONNE M.
    Antibiotic Med Clin Ther (New York); 1957 Jan 16; 4(1):40-4. PubMed ID: 13382115
    [No Abstract] [Full Text] [Related]

  • 17. Development of resistance and cross-resistance in vitro to erythromycin, carbomycin, spiramycin, oleandomycin and streptogramin.
    FINLAND M, JONES WF, NICHOLS RL.
    Proc Soc Exp Biol Med; 1956 Nov 16; 93(2):388-93. PubMed ID: 13379520
    [No Abstract] [Full Text] [Related]

  • 18. NEW ANTIBIOTICS in the fight against resistant staphylococci.
    Am J Pharm Sci Support Public Health; 1956 Sep 16; 128(9):300-4. PubMed ID: 13372757
    [No Abstract] [Full Text] [Related]

  • 19. Studies on the incidence and distribution of antibiotic-resistant Staphylococci.
    HINTON NA, ORR JH.
    J Lab Clin Med; 1957 Apr 16; 49(4):566-72. PubMed ID: 13406392
    [No Abstract] [Full Text] [Related]

  • 20. Rate of development of resistance in Staphylococcus aureus to erythromycin in combination with oleandomycin, vancomycin, or dihydrostreptomycin.
    HALL WH.
    J Lab Clin Med; 1960 Jul 16; 56():83-104. PubMed ID: 14399074
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.